Total Funding
20
58
Total FundingConvertible Note raised
Growth Score 20 in past quarter
-4 pts
Heat Score 58 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
161712
We accelerate drug development and personalized medicine for arthritis using disease-on-a-chip model
- Julie Rosser: CEO
About the Company
At Pregenerate, we use scaleable organ-on-a-chip models to replace animal testing in pharmaceutical research for arthritis treatments. This enables pharmaceutical companies to save billions of dollars and improve the success rates of their drugs to market, in part because we can use human cells in our model.Ultimately, this same technology will
allow us to stratify patients into targeted treatment subgroups, and even to tell each clinical patient what the best treatment is for his or her specific arthritis needs directly.